{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T04:47:19Z","timestamp":1791089239362,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Medical Research"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1016\/j.arcmed.2006.09.010","type":"journal-article","created":{"date-parts":[[2006,12,5]],"date-time":"2006-12-05T07:11:14Z","timestamp":1165302674000},"page":"196-205","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"title":["Effects of Calcitonin, Risedronate, and Raloxifene on Erythrocyte Antioxidant Enzyme Activity, Lipid Peroxidation, and Nitric Oxide in Postmenopausal Osteoporosis"],"prefix":"10.1016","volume":"38","author":[{"given":"Salih","family":"Ozgocmen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huseyin","family":"Kaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ersin","family":"Fadillioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zumrut","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcmed.2006.09.010_bib1","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1006\/bbrc.2001.5747","article-title":"Association between oxidative stress and bone mineral density","volume":"288","author":"Basu","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.arcmed.2006.09.010_bib2","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0009-8981(01)00766-5","article-title":"A duality in the roles of reactive oxygen species with respect to bone metabolism","volume":"318","author":"Sontakke","year":"2002","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.arcmed.2006.09.010_bib3","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1210\/jc.2002-021496","article-title":"Marked decrease in plasma antioxidants in aged osteoporotic women. Results of a cross-sectional study","volume":"88","author":"Maggio","year":"2003","journal-title":"JCEM"},{"key":"10.1016\/j.arcmed.2006.09.010_bib4","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1359\/jbmr.1999.14.1.129","article-title":"Smoking, antioxidant vitamins and risk of hip fracture","volume":"14","author":"Melhus","year":"1999","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.arcmed.2006.09.010_bib5","first-page":"689","article-title":"Is there a role of free oxygen radicals in primary male osteoporosis","volume":"23","author":"Yalin","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.arcmed.2006.09.010_bib6","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s001980050209","article-title":"Mitochondrial DNA deletion associated oxidative stress and severe male osteoporosis","volume":"10","author":"Varanasi","year":"1999","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.arcmed.2006.09.010_bib7","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1096\/fj.99-0896rev","article-title":"Nitric oxide-mediated metabolic regulation during exercise: effect of training in health and cardiovascular disease","volume":"14","author":"Kigwell","year":"2000","journal-title":"FASEB J"},{"key":"10.1016\/j.arcmed.2006.09.010_bib8","first-page":"377","article-title":"Nitric oxide as a physiopathological factor in neuropsychiatric disorders","volume":"18","author":"Akyol","year":"2004","journal-title":"In Vivo"},{"key":"10.1016\/j.arcmed.2006.09.010_bib9","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1046\/j.1365-2567.2001.01261.x","article-title":"Nitric oxide and bone","volume":"103","author":"van't Hof","year":"2001","journal-title":"Immunology"},{"key":"10.1016\/j.arcmed.2006.09.010_bib10","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0002-9440(10)63963-6","article-title":"Endothelial nitric oxide synthase gene-deficient mice demonstrate marked retardation in postnatal bone formation, reduced bone volume, and defects in osteoblast maturation and activity","volume":"158","author":"Aguirre","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.arcmed.2006.09.010_bib11","doi-asserted-by":"crossref","first-page":"7993","DOI":"10.1073\/pnas.130511497","article-title":"Requirement of the inducible nitric oxide synthase pathway for IL-1-induced osteoclastic bone resorption","volume":"97","author":"van't Hof","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.arcmed.2006.09.010_bib12","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1359\/jbmr.1999.14.12.2137","article-title":"Evidence for a pathogenic role of nitric oxide in inflammation-induced osteoporosis","volume":"14","author":"Armour","year":"1999","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.arcmed.2006.09.010_bib13","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/01.blo.0000153990.74837.73","article-title":"Different doses of nitric oxide donor prevent osteoporosis in ovariectomized rats","volume":"435","author":"Hao","year":"2005","journal-title":"Clin Orthop"},{"key":"10.1016\/j.arcmed.2006.09.010_bib14","doi-asserted-by":"crossref","first-page":"5068","DOI":"10.1210\/en.2004-0205","article-title":"Regulation of bone mass and bone turnover by neuronal nitric oxide synthase","volume":"145","author":"van't Hof","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.arcmed.2006.09.010_bib15","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/BF01623062","article-title":"Comparison of a semiquantitative and a quantitative method for assessing vertebral fractures in osteoporosis","volume":"4","author":"Leidig-Bruckner","year":"1994","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.arcmed.2006.09.010_bib16","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s001980050210","article-title":"Quality of life in patients with vertebral fractures: validation of the Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO). Working Party for Quality of Life of the European Foundation for Osteoporosis","volume":"10","author":"Lips","year":"1999","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.arcmed.2006.09.010_bib17","series-title":"Methods of Enzymatic Analysis","first-page":"673","article-title":"Catalase","author":"Aebi","year":"1974"},{"key":"10.1016\/j.arcmed.2006.09.010_bib18","first-page":"158","article-title":"Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase","volume":"70","author":"Paglia","year":"1967","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.arcmed.2006.09.010_bib19","series-title":"Methods in Enzymology, vol. 186, Oxygen Radicals in Biological Systems","article-title":"Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal","author":"Esterbauer","year":"1990"},{"key":"10.1016\/j.arcmed.2006.09.010_bib20","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/clinchem\/34.3.497","article-title":"A simple method for clinical assay of superoxide dismutase","volume":"34","author":"Sun","year":"1988","journal-title":"Clin Chem"},{"key":"10.1016\/j.arcmed.2006.09.010_bib21","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1093\/clinchem\/36.8.1440","article-title":"Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method","volume":"36","author":"Cortas","year":"1990","journal-title":"Clin Chem"},{"key":"10.1016\/j.arcmed.2006.09.010_bib22","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S0006-291X(05)80311-0","article-title":"Stimulation of osteoclastic bone resorption by hydrogen peroxide","volume":"183","author":"Bax","year":"1992","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.arcmed.2006.09.010_bib23","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1172\/JCI114485","article-title":"Oxygen-derived free radicals stimulate osteoclastic bone resorption in rodent bone in vitro and in vivo","volume":"85","author":"Garrett","year":"1990","journal-title":"J Clin Invest"},{"key":"10.1016\/j.arcmed.2006.09.010_bib24","doi-asserted-by":"crossref","first-page":"17497","DOI":"10.1074\/jbc.M409332200","article-title":"Reactive oxygen species stimulates receptor activator of NF-\u03baB ligand expression in osteoblasts","volume":"280","author":"Bai","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.arcmed.2006.09.010_bib25","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1172\/JCI200318859","article-title":"A crucial role for thiol antioxidants in estrogen-deficiency bone loss","volume":"112","author":"Lean","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.arcmed.2006.09.010_bib26","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1210\/en.2004-1021","article-title":"Hydrogen peroxide is essential for estrogen-deficiency bone loss and osteoclasts formation","volume":"146","author":"Lean","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.arcmed.2006.09.010_bib27","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.bbrc.2003.12.073","article-title":"Oxidative stress inhibits osteoblastic differentiation of bone cells by ERK and NF-\u03baB","volume":"314","author":"Bai","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.arcmed.2006.09.010_bib28","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1006\/bbrc.1995.1184","article-title":"The role of reactive oxygen intermediates in osteoclastic bone resorption","volume":"207","author":"Hall","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.arcmed.2006.09.010_bib29","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1083\/jcb.126.3.765","article-title":"NADPH oxidase expression and in situ production of superoxide by osteoclasts actively resorbing bone","volume":"126","author":"Steinbeck","year":"1994","journal-title":"J Cell Biol"},{"key":"10.1016\/j.arcmed.2006.09.010_bib30","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s002239900512","article-title":"The relation of dietary vitamin C intake to bone mineral density: results from the PEPI Study","volume":"63","author":"Hall","year":"1998","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.arcmed.2006.09.010_bib31","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1359\/jbmr.2001.16.1.135","article-title":"Vitamin C supplement use and bone mineral density in postmenopausal women","volume":"16","author":"Morton","year":"2001","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.arcmed.2006.09.010_bib32","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/aje\/154.5.427","article-title":"Relation of ascorbic acid to bone mineral density and self-reported fractures among US adults","volume":"154","author":"Simon","year":"2001","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.arcmed.2006.09.010_bib33","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/ajcn\/82.3.581","article-title":"Lack of a relation between vitamin and mineral antioxidants and bone mineral density: results from the Women's Health Initiative","volume":"82","author":"Wolf","year":"2005","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.arcmed.2006.09.010_bib34","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.bbrc.2003.12.149","article-title":"Selective in vitro antioxidant properties of bisphosphonates","volume":"314","author":"Dombrecht","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.arcmed.2006.09.010_bib35","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1081\/ERC-120022299","article-title":"The effects of estrogen and raloxifene treatment on antioxidant enzymes in brain and liver of ovarectomized female rats","volume":"29","author":"Ozgonul","year":"2003","journal-title":"Endocr Res"},{"key":"10.1016\/j.arcmed.2006.09.010_bib36","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1210\/en.2005-0375","article-title":"Raloxifene, a selective estrogen receptor modulator, reduces carrageenan-induced acute inflammation in normal and ovariectomized rats","volume":"146","author":"Esposito","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.arcmed.2006.09.010_bib37","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.bcp.2004.11.030","article-title":"Sodium nitroprusside-induced osteoblast apoptosis is mediated by long chain ceramide and is decreased by raloxifene","volume":"69","author":"Oliver","year":"2005","journal-title":"Biochem Pharm"},{"key":"10.1016\/j.arcmed.2006.09.010_bib38","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s00296-002-0223-x","article-title":"Possible pathogenetic role of new cytokines in postmenopausal osteoporosis and changes during calcitonin plus calcium therapy","volume":"22","author":"Gur","year":"2002","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.arcmed.2006.09.010_bib39","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1177\/153537020222700202","article-title":"Nitric oxide as the mediators of the antiosteoporotic actions of estrogens, statins, and essential fatty acids","volume":"227","author":"Das","year":"2002","journal-title":"Exp Biol Med"},{"key":"10.1016\/j.arcmed.2006.09.010_bib40","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s00223-003-0161-y","article-title":"NOS isoforms in adult human osteocytes: multiple pathways of NO regulation?","volume":"75","author":"Caballero-Alias","year":"2004","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.arcmed.2006.09.010_bib41","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s002230050011","article-title":"Restoration of ovariectomy-induced osteopenia by nitroglycerine","volume":"66","author":"Wimalawansa","year":"2000","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.arcmed.2006.09.010_bib42","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/8756-3282(96)00005-1","article-title":"Nitric oxide donor alleviates ovariectomy-induced bone loss","volume":"18","author":"Wimalawansa","year":"1996","journal-title":"Bone"},{"key":"10.1016\/j.arcmed.2006.09.010_bib43","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1359\/jbmr.1998.13.11.1755","article-title":"Intermittent use of nitrates increases bone mineral density: the study of osteoporotic fractures","volume":"13","author":"Jamal","year":"1998","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.arcmed.2006.09.010_bib44","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1359\/jbmr.2000.15.11.2240","article-title":"Nitroglycerin therapy is as efficacious as standard estrogen replacement therapy (premarin) in prevention of oophorectomy-induced bone loss: a human pilot clinical study","volume":"15","author":"Wimalawansa","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.arcmed.2006.09.010_bib45","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1359\/JBMR.041121","article-title":"L-arginine, the natural precursor of NO, is not effective for preventing bone loss in postmenopausal women","volume":"20","author":"Baecker","year":"2005","journal-title":"J Bone Miner Res"}],"container-title":["Archives of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440906003389?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440906003389?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:32:43Z","timestamp":1759260763000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0188440906003389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["S0188440906003389"],"URL":"https:\/\/doi.org\/10.1016\/j.arcmed.2006.09.010","relation":{},"ISSN":["0188-4409"],"issn-type":[{"value":"0188-4409","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of Calcitonin, Risedronate, and Raloxifene on Erythrocyte Antioxidant Enzyme Activity, Lipid Peroxidation, and Nitric Oxide in Postmenopausal Osteoporosis","name":"articletitle","label":"Article Title"},{"value":"Archives of Medical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcmed.2006.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 IMSS. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}